Bellerophon Therapeutics Financials

Bellerophon Therapeutics Stock Summary

Bellerophon Therapeutics competes with Bio Path, Capricor Therapeutics, NextCure, Zura Bio, and Immix Biopharma. Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Bellerophon Therapeutics, Inc. was founded in 2009 and is headquartered in Warren, New Jersey. Bellerophon Ther operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 20 people.

Bellerophon Therapeutics Key Financial Ratios

Bellerophon Therapeutics' financial ratios allow both analysts and investors to convert raw data from Bellerophon Therapeutics' financial statements into concise, actionable information that can be used to evaluate the performance of Bellerophon Therapeutics over time and compare it to other companies across industries.

Bellerophon Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Bellerophon Therapeutics's current stock value. Our valuation model uses many indicators to compare Bellerophon Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bellerophon Therapeutics competition to find correlations between indicators driving Bellerophon Therapeutics's intrinsic value. More Info.Bellerophon Therapeutics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Bellerophon Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bellerophon Therapeutics' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Bellerophon Therapeutics Market Pulse

Along with financial statement analysis, the daily predictive indicators of Bellerophon Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Bellerophon Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Bellerophon Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Bellerophon Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Bellerophon Therapeutics's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

If you are still planning to invest in Bellerophon Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bellerophon Therapeutics' history and understand the potential risks before investing.